Soluble syndecan-1 levels in different plasma cell dyscrasias and in different stages of multiple myeloma.
We measured serum levels of syndecan-1 in patients with multiple myeloma (MM), solitary plasmocytoma and monoclonal gammopathy of undetermined significance (MGUS). We then studied serum syndecan-1 levels in MM patients stratified by the Durie-Salmon staging system and the correlation of syndecan-1 levels with well known independent prognostic factors of MM.
Jánosi
Judit
J
Sebestyén
Anna
A
Mikala
Gábor
G
Németh
Júlia
J
Kiss
Zoltán
Z
Vályi-Nagy
István
I
D006801:Humans; D008562:Membrane Glycoproteins / Q000097:blood*; D009101:Multiple Myeloma / Q000097:blood*; D010265:Paraproteinemias / Q000097:blood*; D011509:Proteoglycans / Q000097:blood*; D053668:Syndecan-1; D053667:Syndecans
D008562:Membrane Glycoproteins; D011509:Proteoglycans; C508241:SDC1 protein, human; D053668:Syndecan-1; D053667:Syndecans